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Abstract 
The modifications of intracellular redox balance leads to important cellular changes in many cell types. Here, a causal 
relationship between redox state and monocytic differentiation induced by isoliquiritigennin(ISL) have been studied 
in the human acute promyelocytic leukaemia HL-60 cells. The modulations of intracellular reactive oxygen species 
levels by D, L-buthionine-(S, R) sulfoximide (BSO), and N-acetyl-L-cysteine (NAC) caused inducer- and time-
dependent or stage-specific effects on HL-60 cell growth inhibition and differentiation. ISL increased intracellular 
Superoxide anions (O2.-) that was completely inhibited by BSO and NAC. ISL increased NBT reduction ability and 
the expressions of surface antigens CD11b and CD14 were completely inhibited by BSO and NAC. These 
observations suggest a critical role of redox state in determining HL-60 cell behaviour and provide new insights into 
the complex effects of redox perturbations on the intracellular signalling network. 
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1.Introduction 
Recent evidence suggests that the redox state of the cell maybe important to control cell growth, 
differentiation and apoptosis [1-4]. Superoxide anions are the primary reactive oxygen species (ROS) 
generated by normal cellular metabolism [5]. Tumour cells with respect to normal counterparts exhibit the 
increase in metabolic rate and elevated intracellular ROS levels causing the maintenance of cellcycle 
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activity and resistance to apoptosis [6-8]. The maturation of differentiating granulocytes leads to the 
superoxide anion production as well [9]. Excessive accumulation of ROS is toxic but the production of 
intracellular ROS is tightly regulated by antioxidant molecules and ROS-scavenging enzymes [10]. Some 
evidence points to the beneficial roles of oxidants or antioxidants as chemotherapeutic agents. In acute 
myeloid leukaemia blasts, the prooxidant agent L-buthionine-(S, R) sulfoximide (BSO) promotes high 
level of ROS generation by causing reduced glutathione (GSH) depletion[11]  and significantly enhances 
the toxicity of many anti-cancer agents (Bailey 1998). N-Acetyl-L-cysteine (NAC), a precursor of 
cysteins, elevates the GSH level, scavenges intracellular ROS, and exerts protective effects from initiating 
apoptosis [12], cancer cell invasion, and metastasis [13]. There are conflicting observations that ROS may 
have pro-survival effect through activation of antiapoptotic redox-sensitive signalling pathways [14] or the 
inhibition of ROS generation by antioxidants may result in differentiation [15]. 
The aim of this study was to investigate the role of intracellular redox state modulated by oxidant BSO 
and antioxidant NAC on relationship among ROS levels, and cell commitment to differentiate toward 
granulocytes in the human promyelocytic leukaemia HL-60 cells. The task of this study was to reveal 
whether the modulation of cellular redox state may be useful in leukaemia therapy. We report here that the 
modulation of intracellular ROS levels causes different effects on HL-60 cell growth and survival, and 
leads to inducer-dependent or stage-specific changes in HL-60 cell differentiation via a redox-sensitive 
way. 
2.METHODS AND MATERIALS 
2.1.Materials 
Isoliquiritigenin (ISL) was purchased from Jiangxi Herb Tiangong Technology Co., Ltd. (Jiangxi, 
China). Culture medium (RPMI 1640), glutamine and DMSO were purchased from Sigma Chemical Co. 
(St. Louis, MO). Fetal bovine serum (FBS) was purchased from Tianjin Hao Yang Biological Manufacture 
CO., Ltd (Tianjin, China); Dihydroethidium (DHE) was purchased from beyotime institute of 
biotechnology (shanghai, China); Penicillin and streptomycin were obtained from Shandong Sunrise 
Pharmaceutical Co., Ltd. (Shandong, China). All other chemicals were of analytical grade and 
commercially available. 
2.2.Cell line and cell culture 
HL-60 human promyelocytic leukemia cells were purchased from China Center for Type Culture 
Collection (Wuhan, China). The cells were cultured in RPMI 1640 medium supplemented with 10% fetal 
calf serum, 100 U/ml penicillin and 100 ȝg/ml streptomycin in 5% CO2 and humidified in a 37°C incubator. 
For each experiment, logarithmically growing HL-60 cells were used at a density 1×105 cells/ml. In 
pretreatment experiments, cells were incubated with NAC and BSO for 24 h, the compound was removed 
by centrifugation at 300×g for 5 min. The pelleted cells were rinsed once with fresh medium and 
resuspended in the medium containing a required compound alone or in combination with another 
compound. Treated cells were cultured and harvested at the time points indicated. Three independent 
experiments were performed with control and treated flasks. The stock solutions used were: ISL(100mg/ml) 
in DMSO; BSO (2mM) in RPMI medium; NAC (1000 mM) was dissolved in RPMI medium and taken to 
neutrality by adding 0.1 N NaOH. The required volume of stock solutions was added to cell culture 
medium to achieve the desired concentration. 
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2.3.Cell viability and proliferation  
Viable cells were evaluated by the the MTT assay [16]. This assay is based on the reduction of the yellow 
colored MTT by mitochondrial dehydrogenase of metabolically active cells to a purple-blue formazan. 
Cells were plated in 96-well plates, after drugs treated, the plates were centrifuged and the medium was 
replaced by fresh medium (200 ȝl) containing 0.5 mg/ml MTT. After 3 h incubation, the MTT formazan 
was dissolved in 150 ȝl DMSO, and the absorbance was measured using a microplate reader (Thermo 
Varioskan Flash 3001, USA). Drug effect was quanti¿ed as the percentage of control absorbance of 
reduced dye at 550 nm. The growth inhibition of treated cells was expressed as the percentage of total cell 
number from untreated control (100%). 
2.4.Determination of superoxide anion (O2.-) 
HL-60 cells (105cells/ml) were cultured with ISL at 0, 2.5, 5.0, 10.0 ȝg/ml and combination with NAC 
and BSO in RPMI 1640 medium containing 10% FBS for 8h. Dihydroethidium was then added or not to 
the cells treated with each drug at a ¿nal concentration of 10 ȝM and incubated for 30 min. Fluorescence 
was read at 515 nm excitation and 595 nm emission in a Àuorescence plate reader (Thermo Varioskan 
Flash 3001). The wells containing drug but not DHE acted as blanks for each sample. Then the stained 
cells were observed under a confocal laser-scanning microscope (Zeiss LSM 510 META). 
2.5.NBT reductive activity  
The degree of differentiation was assayed by the ability of cells to reduce NBT to insoluble blue-black 
formazan on stimulation by PMA. Cell suspension (100 ȝl) was mixed with an equal volume of 0.2% NBT 
dissolved in phosphate-buffered saline (PBS) containing 40 ng/ml PMA, and incubated at 37°C for 30 min. 
NBT-positive cells were counted in a haemocytometer. At least 400 cells were scored for each 
determination. NBT-positive cell number was expressed as a percentage of the viable cell number. 
2.6.Reverse transcription-polymerase chain reaction(RT-PCR) 
Semiquantitative reverse transcription-PCR (RT-PCR) was performed to examine the mRNA 
expression of CD11b and CD14. Cells were cultured with inducing agents for indicated periods of time. 
Total cellular RNA was extracted using TRIzol reagent. Then cDNA was synthesized with the use of 3ȝl 
total RNA primed with oligod (T) (deoxy-thymidine) in 25 ml reaction solution. The resulting total cDNA 
was used in the polymerase chain reaction. PCR products were subjected to 1.5% agarose gel 
electrophoresis. The bands were visualized by GoldenView staining and observed under ultraviolet light. 
Theprimers sequences were as follows: 
CD11b  
Forward-5’-GCCCAGACCACACGTAGC-3’ 
Reverse-5’-TTGCACACACTCACACATGG -3’(203bp); 
CD14 
Forward-5’- AAGATTTCCGCTGCGTC -3’ 
Reverse-5’-TGTCAAGCATACTGCCG-3’(165 bp); 
GAPDH 
Forward-5’-CAAGGTCATCCATGACA-ACTTTG-3’ 
Reverse-5’-GTCCACCACCCTGTTGCTGTAG-3’ (496bp) 
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3.RESULTS 
3.1.Effects of BSO and NAC on growth of proliferation 
The modulation of the intracellular level of ROS was performed by the use of oxidant BSO, which 
selectively inhibits GSH synthesis and increases ROS levels, and antioxidant NAC, which increases 
intracellular levels of GSH and directly scavenges oxygen radicals. In the initial experiments, we have 
studied dose- and time-dependency of human promyelocytic leukaemia HL-60 cell growth under stress 
conditions by ISL alone or in combination with various concentrations of BSO (250-750 ȝM) and NAC (5-
15 mM). The curves presented in Fig. 1 illustrate the time course of HL-60 cell growth inhibition. The 
drugs caused differences in their potency to inhibit cell growth during 4d of incubation, with BSO being 
most efficient than NAC. All concentrations combination with NAC used induced cell growth inhibition 
were lower than ISL alone on Day 3, while all doses of combination with BSO caused higher growth 
inhibition than ISL alone on Day 3.  
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Fig.1. The growth inhibition of HL-60 cells by ISL alone or in combination with BSO or NAC Cells were exposed to increasing 
concentrations of BSO (250-750 ȝM) or NAC (5-15 mM) with ISL for 4 d. growth inhibition was determined by the the MTT assay 
as the percentage of the total number of treated cells relative to the total number of untreated control (100%). Results are expressed 
as means ±SD of four independent experiments. 
3.2.ISL elevated the intracellular O2.- formation 
DHE was used to measure the effect of ISL on the level of intracellular O2.- in HL-60 cells. As shown in 
Fig. 2A, ISL treatment signi¿cantlly elevated the intracellular O2.- levels in HL-60 cells in a dose-
dependent manner. It was elevated to 148.21% in the 10 ȝg/ml ISL-treated group as compared to the 
vehicle control group at 4h. The Àuorescence intensity was observed raised under a confocal laser-scanning 
microscope after 8 h treatment with ISL (Fig. 2B). 
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Fig.2. Effects of ISL on the intracellular O2.- formation of HL-60 cells. (A) Intracellular O2.- Levels were measured by DHE, after 
4h treatment with ISL. The Àuorescence intensity was expressed as the percentage of vehicle control. Data are presented as 
means±SEM from three independent experiments. *Pİ0.05, **Pİ0.01, vs vehicle control. (B) Effects of the intracellular O2.- 
Levels of HL-60 cells induced by ISL. The representative pictures of HL-60 cells with or without ISL treatment. HL-60 cells were 
treated with 1–10 ȝg/ml ISL for 8h and stained with DHE, Then the stained cells were observed under a confocallaser-scanning 
microscope. (all picture magni¿cations 20×). 
ISL elevated the intracellular O2.- was prevented by pretreatment of the cells with 2.5 ȝM NAC and 0.2 
mM BSO. The superoxide anion output of cells exposed to ISL after treatment with NAC was decreased 
by about 41.96% and BSO was decreased by about 35.7% compared with that of cells treated with ISL 
alone after 4h (Fig. 3). 
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Fig.3. NAC and BSO hindered the increased output of superoxide anion induced by ISL. HL-60 cells were treated with or without 
2.5 ȝM NAC and 0.2 mM BSO, and then the cells were treated with ISL. The output of superoxide anion was measured after 72 h. 
The values are expressed as means ± SEM of three independent experiments. *P < 0.05, **P < 0.01 versus the control.  
3.3.3.3.Effects of BSO and NAC on differentiation in HL-60 cells 
The role of redox state in the ISL-induced differentiation was assessed. The phorbol-12-myristate-13-
acetate-stimulated formation of superoxide is a typical character of mature granulocytes [17]. So the NBT 
658  Na Chen et al. / Procedia Environmental Sciences 8 (2011) 653 – 660
reduction assay was performed to show the mature differentiation induced by ISL. After 72 h treatment, 
ISL increased the NBT reductive activity. NAC and BSO blocked the ISL-induced differentiation, as 
indicated by NBT reduction ability (Fig. 4A). To further con¿rm the ability of ISL to induce differentiation 
of HL-60 cells, the surface expression of the monocytic and myelomonocytic markers CD14 and CD11b 
[18-20], respectively, were determined. The results demonstrated that ISL was a potent inducer of 
myelomonocytic differentiation, leads increase of CD14 and CD11b expressions of mRNA (Fig. 4B), and 
this increase were blocked by NAC and BSO. 
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Fig.4. NAC and BSO blocks the differentiation in HL-60 cells induced by ISL. HL-60 cells were treated with or without 2.5 ȝM 
NAC and 0.2 mM BSO, and then the cells were treated with ISL. ˄A˅The NBT reducing activity was measured after 72 h. The 
values are expressed as means ± SEM of three independent experiments. *P < 0.05, **P < 0.01 versus the control. (B) CD11b and 
CD14 mRNA expression. These results are representative of 3 independent experiments. 
4.DISCUSSION 
Redox regulation is an important mechanism for oxidant-induced changes in gene expression that 
influence overall cellular responses. The results of our study showed that redox balance perturbations cause 
unexpected and stimulus-specific effects on promyelocytic leukaemia HL-60 cell differentiation related to 
the timing and degree of ROS modulation. First, the redox state disturbances in proliferating HL-60 cells 
by prooxidant BSO and antioxidant NAC (being most efficient) that was enhanced and decreased cell 
growth inhibition caused by ISL. 
Second, our study clarified the influence of redox perturbations on promyelocytic leukaemia HL-60 cell 
differentiation when ROS modulators were added before the induction of differentiation, during the 
commitment stage and full time of ISL-mediated differentiation. ISL increased intracellular Superoxide 
anions (O2.-) that was inhibited by BSO and NAC. Meanwhile, ISL increased NBT reduction ability and 
the expressions of surface antigens CD11b and CD14 were completely inhibited by BSO and NAC. The 
surprising observations were that the presence of BSO and NAC during ISL-mediated differentiation 
inhibited cell maturation. It is possible that intracellular ROS can play stimulatory or inhibitory roles 
depending on type of inducer, which triggers cellular responses using different signalling pathways. 
In conclusion, we have demonstrated in this report that the change in intracellular ROS levels resulted in 
different, a context-specific cellular response, such as differentiation. ROS can have adverse or beneficial 
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effects depending on cellular redox environment, concentration and duration of ROS exposition. From a 
therapeutic point of view, oxidant BSO might serve as an inducer of differentiation in proliferating 
leukaemia cells; antioxidant NAC that prevents cell growth but protects from cell death is much less 
efficacious; the selective combinatorial treatments that potentiate cell differentiation and apoptosis and 
concerted stimulatory action of ISL would be useful for anti-cancer therapy. 
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